Kim Reiss Binder, MD

Trials

Studies that name Kim Reiss Binder, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:20 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07832630 · Saruparib in HRDsig+ Solid Tumors

  Abramson Cancer Center at Penn Medicine · not yet recruiting · Malignant Neoplastic Disease (Disorder) · principal investigator
• Ph1/Ph2
  NCT04657068 · A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  Artios Pharma Ltd · recruiting · Advanced Cancer, Metastatic Cancer, Ovarian Cancer · principal investigator
• Ph2
  NCT04171700 · A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

  pharmaand GmbH · terminated · Solid Tumor · principal investigator
• Ph1
  NCT03730948 · DC Vaccine in Colorectal Cancer

  University of Pennsylvania · terminated · Colorectal Cancer · principal investigator
• Early Ph1
  NCT03427021 · A Randomized Study to Establish the Efficacy of Oral Ice Exposure During Oxaliplatin Infusion in Preventing Oral Cold Sensitivity

  Abramson Cancer Center at Penn Medicine · terminated · GI Patients on Oxaliplatin Containing Regimen · principal investigator
• Ph2
  NCT03140670 · Maintenance Rucaparib in BRCA1, BRCA2 or PALB2 Mutated Pancreatic Cancer That Has Not Progressed on Platinum-based Therapy

  Abramson Cancer Center at Penn Medicine · terminated · Pancreatic Cancer · principal investigator
• Ph1
  NCT02906397 · Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC)

  Abramson Cancer Center at Penn Medicine · completed · ADVANCED HEPATOCELLULAR CARCINOMA (HCC) · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 13:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Integrated Discovery Pipeline for Tumor Neoantigens
  R01CA204261 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Beatriz M. Carreno, Gerald P Linette · fiscal years 2016 to 2020
  Named on NCT03730948